WuXi PharmaTech (WX) Posts Q3 non-GAAP EPS of $0.24, Tops by 9c
More News related to WX
- WuXi PharmaTech to Present at 28th Annual J.P. Morgan Healthcare Conference
- Halter USX China Index Up 61.75% for 2009
- WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing
- WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
- WuXi PharmaTech (WX) Posts Q3 non-GAAP EPS of $0.24, Tops by 9c
More News related to Earnings
- Textainer (TGH) Tops Q4 Earnings Views
- Sprint Nextel (S) Q4 Losses Narrow, But Miss Expectations
- Baldwin Technology (BLD) Posts Q2 Loss of $0.03, Misses by 4c
- Aastrom Biosciences, Inc. (ASTM) Posts In-Line Q2 Loss of $0.03; Revs Lower Y/Y
- Computer Sciences (CSC) Tops Q3 EPS by 13c; Reaffirms
WuXi PharmaTech Co., Ltd. (NYSE: WX) reports Q3 non-GAAP EPS of $0.24, 9 cents better than the analyst estimate of $0.15. Revenue for the quarter was $70 million, which compares to the estimate of $70.22 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
